Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer

Bayne, Lauren J., Beatty, Gregory L., Jhala, Nirag, Clark, Carolyn E., Rhim, Andrew D., Stanger, Ben Z., Vonderheide, Robert H.·2012·Cancer Cell

DOI 10.1016/j.ccr.2012.04.025

Cited by (952)

Items 201–300 of 952

Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma
Yumeng Mao, Nina Eißler, Katarina Le Blanc, John Inge Johnsen, Per Kogner, Rolf W. Kiessling · 2016 · Clinical Cancer Research
Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer
Shintaro Takeuchi, Muhammad Baghdadi, Takahiro Tsuchikawa, Haruka Wada, Toru Nakamura, Hirotake Abe, Sayaka Nakanishi, Yuu Usui, Kohtaro Higuchi, Mizuna Takahashi et al. · 2015 · Cancer Research
Spatiotemporally Controllable Distribution of Combination Therapeutics in Solid Tumors by Dually Modified Bacteria
Lu Wang, Zhenping Cao, Mengmeng Zhang, Sisi Lin, Jinyao Liu · 2021 · Advanced Materials
Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy
Haixia Long, Qingzhu Jia, Liuyang Wang, Wen‐Feng Fang, Zhongyu Wang, Tao Jiang, Fei Zhou, Jin Zheng, Jiani Huang, Li Zhou et al. · 2022 · Cancer Cell
Complex role for the immune system in initiation and progression of pancreatic cancer
Kristin S. Inman · 2014 · World Journal of Gastroenterology
Metastatic progression is associated with dynamic changes in the local microenvironment
Nicole M. Aiello, David Lawrence Bajor, Robert J. Norgard, Amine Sahmoud, Neha Bhagwat, Minh N. Pham, Toby C. Cornish, Christine A. Iacobuzio–Donahue, Robert H. Vonderheide, Ben Z. Stanger · 2016 · Nature Communications
The biological underpinnings of therapeutic resistance in pancreatic cancer
Gregory Lawrence Beatty, Gregor Werba, Costas Andreas Lyssiotis, Diane M. Simeone · 2021 · Genes & Development
Role of immune cells in pancreatic cancer from bench to clinical application
Jae Hyuck Chang, Yongjian Jiang, Venu Gopal Pillarisetty · 2016 · Medicine
GEMMs as preclinical models for testing pancreatic cancer therapies
Aarthi Gopinathan, Jennifer P. Morton, Duncan Ian Jodrell, Owen James Sansom · 2015 · Disease Models & Mechanisms
Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer
Delphine Goehrig, Jérémy Nigri, Rémi Samain, Zhichong Wu, Paola Cappello, Gaëlle Gabiane, Xinyi Zhang, Yajie Zhao, In-San Kim, Marie Chanal et al. · 2018 · Gut
Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer
Jinyang Li, Salina Yuan, Robert J. Norgard, Fangxue Yan, Yu Huining Sun, Il‐Kyu Kim, Allyson J. Merrell, Yogev Sela, Yanqing Jiang, Natarajan V. Bhanu et al. · 2020 · Cancer Discovery
Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling
Priyanshu Shukla, Sriya Yeleswarapu, Marcel Alexander Heinrich, Jai Prakash, Falguni Pati · 2022 · Biofabrication
An Immunosuppressive Dendritic Cell Subset Accumulates at Secondary Sites and Promotes Metastasis in Pancreatic Cancer
Justin A. Kenkel, William W. Tseng, Matthew G. Davidson, Lorna L. Tolentino, Okmi Choi, Nupur Bhattacharya, E. Scott Seeley, Daniel A. Winer, Nathan Edward Reticker-Flynn, Edgar G. Engleman · 2017 · Cancer Research
Systemic Reprogramming of Monocytes in Cancer
Máté Kiss, Aarushi Audhut Caro, Geert Raes, Damya Laoui · 2020 · Frontiers in Oncology
Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps
Gregory Lawrence Beatty, Mark H. O’Hara · 2016 · Pharmacology & Therapeutics
Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer
Heidi Griesmann, Christof Drexel, Nada Milosevic, Bence Sipos, Jonas Rosendahl, Thomas Mathias Gress, Patrick Michl · 2016 · Gut
Therapeutic options for the management of pancreatic cancer
Maria L Rossi · 2014 · World Journal of Gastroenterology
Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment
К.-С. Н. Атретханы, Marina S. Drutskaya, Sergei A. Nedospasov, Sergei I. Grivennikov, Dmitry V. Kuprash · 2016 · Pharmacology & Therapeutics
Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease
Joseph Markowitz, Taylor Brooks, Megan Christina Duggan, Bonnie K. Paul, Xueliang Jeff Pan, Lai Wei, Zachary B. Abrams, Eric A. Luedke, Gregory B. Lesinski, Bethany L. Mundy-Bosse et al. · 2014 · Cancer Immunology Immunotherapy
A mathematical model for pancreatic cancer growth and treatments
Yoram Louzoun, Chuan Xue, Gregory B. Lesinski, Avner Friedman · 2014 · Journal of Theoretical Biology
Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy
Adeleye Oluwatosin Adeshakin, Wan Liu, Funmilayo Oladunni Adeshakin, Lukman Olalekan Afolabi, Mengqi Zhang, Guizhong Zhang, Lulu Wang, Zhihuan Li, Lilong Lin, Qin Cao et al. · 2021 · Cellular Immunology
Pancreatic cancer and its stroma: A conspiracy theory
Zhihong Xu · 2014 · World Journal of Gastroenterology
Deciphering the role of stroma in pancreatic cancer
Meghna Waghray, Malica Yalamanchili, Marina Pasca di Magliano, Diane M. Simeone · 2013 · Current Opinion in Gastroenterology
Chemotherapy and tumor microenvironment of pancreatic cancer
Liu, Qiaofei, Liao, Quan, Zhao, Yupei · 2017 · Cancer Cell International
Inflammation-Induced NFATc1–STAT3 Transcription Complex Promotes Pancreatic Cancer Initiation by Kras G12D
Sandra Baumgart, NM Chen, Jens Thomas Siveke, Alexander Otto König, Jin‐San Zhang, Shiv K. Singh, Elmar Wolf, Marek Bartkuhn, Iréne Esposito, Elisabeth Heßmann et al. · 2014 · Cancer Discovery
Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer
Tulasigeri M. Totiger, Supriya Srinivasan, Venkatakrishna Rao Jala, Purushottam Lamichhane, Austin R. Dosch, Alexander A. Gaidarski, Chandrashekhar G. Joshi, Shobith Rangappa, Jason A. Castellanos, Praveen Kumar Vemula et al. · 2018 · Molecular Cancer Therapeutics
Tuning the Tumor Myeloid Microenvironment to Fight Cancer
Nadine S. Jahchan, Adriana M. Mujal, Joshua L. Pollack, Mikhail Binnewies, Venkataraman Sriram, Leonard M. Reyno, Matthew F. Krummel · 2019 · Frontiers in Immunology
IL-17-Producing Cells in Tumor Immunity: Friends or Foes?
Da‐Sol Kuen, Byung‐Seok Kim, Yeonseok Chung · 2020 · Immune Network
Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs
Mastio, Jérôme, Condamine, Thomas, Dominguez, George, Kossenkov, Andrew V., Donthireddy, Laxminarasimha, Veglia, Filippo, Lin, Cindy, Wang, Fang, Fu, Shuyu, Zhou, Jie et al. · 2019 · Journal of Experimental Medicine
Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy
Michelle Nicole Messmer, Colleen S. Netherby, Debarati Banik, Scott I. Abrams · 2014 · Cancer Immunology Immunotherapy
Stromal reengineering to treat pancreas cancer
Ingunn M. Stromnes, Kathleen E. DelGiorno, Philip D. Greenberg, Sunil R. Hingorani · 2014 · Carcinogenesis
The complex landscape of pancreatic cancer metabolism
C. M. Sousa, Alec C. Kimmelman · 2014 · Carcinogenesis
Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment
Kendall C. Shibuya, Vikas Goel, Wei Xiong, Jonathan G. Sham, Seth M. Pollack, Allison M. Leahy, Samuel H. Whiting, Matthew M. Yeh, Cassian Yee, Stanley R. Riddell et al. · 2014 · PLoS ONE
Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade
Sebastian Rune Nielsen, Jan E. Strøbech, Edward R. Horton, René Jackstadt, Anu Laitala, Marina Crespo Bravo, Giorgia Maltese, Adina R. D. Jensen, Raphael Reuten, Maria Rafaeva et al. · 2021 · Nature Communications
B cell–Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer
Bhalchandra Mirlekar, Daniel E. Michaud, Samuel J. Lee, Nancy Porterfield Kren, Cameron Harris, Kevin G. Greene, Emily C. Goldman, Gaorav P. Gupta, Ryan Courtney Fields, William G. Hawkins et al. · 2020 · Cancer Immunology Research
Macropinocytosis in cancer-associated fibroblasts is dependent on CaMKK2/ARHGEF2 signaling and functions to support tumor and stromal cell fitness
Zhang, Yijuan, Recouvreux, M. Victoria, Jung, Michael, Galenkamp, Koen M.O., Li, Yunbo, Zagnitko, Olga, Scott, David A., Lowy, Andrew M., Commisso, Cosimo · 2021 · Cancer Discovery
Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF–induced neutrophil recruitment
Vernon T. Phan, Xiumin Wu, Jason H. Cheng, Rebecca X. Sheng, Alicia S. Chung, Guanglei Zhuang, Christopher Tran, Qinghua Song, Marcin Kowanetz, Amy Sambrone et al. · 2013 · Proceedings of the National Academy of Sciences
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes
Alessandro Di Federico, Mirta Mosca, Rachele Pagani, Riccardo Carloni, Giorgio Frega, Andrea De Giglio, Alessandro Rizzo, Dalia Ricci, Simona Tavolari, Mariacristina Di Marco et al. · 2022 · Cancers
Radiotherapy and CD40 Activation Separately Augment Immunity to Checkpoint Blockade in Cancer
Andrew J. Rech, Hannah Dada, Jonathan J. Kotzin, Jorge Henao‐Mejia, Andy J. Minn, Christina Twyman-Saint Victor, Robert H. Vonderheide · 2018 · Cancer Research
CD40 immunotherapy for pancreatic cancer
Robert H. Vonderheide, David Lawrence Bajor, Rafael Winograd, Rebecca A. Evans, Lauren J. Bayne, Gregory Lawrence Beatty · 2013 · Cancer Immunology Immunotherapy
Epithelial and stromal co-evolution and complicity in pancreatic cancer
Hingorani, Sunil R. · 2023 · Nature Reviews Cancer
Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells
Peng Xiao, Xiaopeng Wan, Bijun Cui, Yang Liu, Chenyang Qiu, Jiabing Rong, Mingzhu Zheng, Yinjing Song, Luoquan Chen, Jia He et al. · 2015 · OncoImmunology
Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer
Guoliang Yang, Wenyan Shen, Yan Zhang, Mengyao Liu, Lianhua Zhang, Qiang Liu, Hui Hui Lu, Juanjie Bo · 2017 · Oncotarget
Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases
Mitchell Thorn, Prajna Guha, Marissa Cunetta, N. Joseph Espat, George Miller, Richard Paul Junghans, Steven C. Katz · 2016 · Cancer Gene Therapy
S100A9 Regulates MDSCs-Mediated Immune Suppression via the RAGE and TLR4 Signaling Pathways in Colorectal Carcinoma
Mao Huang, Rui Wu, Lu Chen, Qi Peng, Shue Li, Yan Zhang, Lan Zhou, Liang Duan · 2019 · Frontiers in Immunology
IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma
Kristen B. Long, Graham M. Tooker, Evan Tooker, Santiago Lombo Luque, Jae Woo Lee, Xiaoqing Pan, Gregory Lawrence Beatty · 2017 · Molecular Cancer Therapeutics
The Interplay among miRNAs, Major Cytokines, and Cancer-Related Inflammation
Chiranjib Chakraborty, Ashish Ranjan Sharma, Garima Sharma, Sang‐Soo Lee · 2020 · Molecular Therapy — Nucleic Acids
Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis
Brian Yong Lee, Elizabeth K. J. Hogg, Christopher Below, Alexander Kononov, Adrián Blanco‐Gómez, Felix Heider, Jingshu Xu, Colin Hutton, Xiaohong Mary Zhang, Tamara Scheidt et al. · 2021 · Nature Communications
Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma
W-Q Wang, L. Liu, H-X Xu, C-T Wu, J-F Xiang, Jiejie Xu, C. Liu, J Long, Q-X Ni, Xianjun Yu · 2016 · British journal of surgery
Breast cancer–derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment
Xinming Su, Yalin Xu, Gregory C. Fox, Jingyu Xiang, Kristin A. Kwakwa, Jennifer L. Davis, Jad I. Belle, Wen‐Chih Lee, Winghing Wong, Francesca Fontana et al. · 2021 · Journal of Clinical Investigation
CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice
Zhang, Yaqing, Yan, Wei, Mathew, Esha, Bednar, Filip, Wan, Shanshan, Collins, Meredith A., Evans, Rebecca A., Welling, Theodore H., Vonderheide, Robert H., di Magliano, Marina Pasca · 2014 · Cancer Immunology Research
CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma
Xiaomeng Liu, Rong Tang, Jin Xu, Zhen Tan, Chen Liang, Qingcai Meng, Yubin Lei, Jie Hua, Yiyin Zhang, Jiang Liu et al. · 2023 · Gut
Cancer cell-intrinsic mechanisms driving acquired immune tolerance
Ehsan Ghorani, Charles Swanton, Sergio A. Quezada · 2023 · Immunity
Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches
Truong, Linh-Huyen, Pauklin, Siim · 2021 · Cancers
The prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis
Reichert, Maximilian, Takano, Shigetsugu, von Burstin, Johannes, Kim, Sang-Bae, Lee, Ju-Seog, Ihida-Stansbury, Kaori, Hahn, Christopher, Heeg, Steffen, Schneider, Günter, Rhim, Andrew D. et al. · 2013 · Genes & Development
Myeloid-derived suppressor cells and their role in pancreatic cancer
Matthew Pergamo, George Miller · 2016 · Cancer Gene Therapy
Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression
Jeremy S. Wilson, Romano C. Pirola, Minoti Vivek Apte · 2014 · Frontiers in Physiology
Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?
İbrahim Halil Şahin, Gokce Askan, Zhengming Hu, Eileen Mary O'Reilly · 2017 · Annals of Oncology
The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma
Demi S. Houg, Maarten F. Bijlsma · 2018 · Molecular Cancer
Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis
Gaia Bellomo, Carolyn Rainer, Valeria Quaranta, Yuliana Astuti, Meirion Raymant, Elzbieta Boyd, Ruth Stafferton, Fiona Campbell, Paula Ghaneh, Christopher Michael Halloran et al. · 2022 · Gut
Macrophages: Gatekeepers of Tissue Integrity
Yonit Lavin, Miriam Mérad · 2013 · Cancer Immunology Research
Impact of tumour associated macrophages in pancreatic cancer
Ainhoa Mielgo, Michael C. Schmid · 2013 · BMB Reports
G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers
Wenbin Li, Xinghua Zhang, Yongkang Chen, Yibin Xie, Jiancheng Liu, Qiang Feng, Yi Wang, Wei Yuan, Jie Ma · 2016 · Protein & Cell
Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review
Rexiati Ruze, Jianlu Song, Xinpeng Yin, Yuan Chen, Ruiyuan Xu, Chengcheng Wang, Yupei Zhao · 2023 · Signal Transduction and Targeted Therapy
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Alain Michielin, Mikaël J. Pittet · 2024 · Nature reviews. Cancer
Circulating monocyte chemoattractant protein‐1 (MCP‐1) is associated with cachexia in treatment‐naïve pancreatic cancer patients
Erin E. Talbert, Heather L. Lewis, Matthew R. Farren, Mitchell L. Ramsey, Jeffery M. Chakedis, Priyani V. Rajasekera, Ericka N. Haverick, Angela Sarna, Mark Bloomston, Timothy Michael Pawlik et al. · 2018 · Journal of Cachexia Sarcopenia and Muscle
High-salt diet inhibits tumour growth in mice via regulating myeloid-derived suppressor cell differentiation
Wei He, Jinzhi Xu, Ruoyu Mu, Qiu Li, Dalun Lv, Zhen Dong Huang, Junfeng Zhang, Chunming Wang, Lei Dong · 2020 · Nature Communications
Targeting tumor-associated macrophages to combat pancreatic cancer
Ran Cui, Wen Yue, Edmund C. Lattime, Mark N. Stein, Qing Xu, Xiang‐Lin Tan · 2016 · Oncotarget
Myeloid‐derived suppressor cells as effectors of immune suppression in cancer
Athalia Rachel Pyzer, Leandra Cole, Jacalyn M. Rosenblatt, David Avigan · 2016 · International Journal of Cancer
Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment
Naoki Horikawa, Kaoru Abiko, Noriomi Matsumura, Tsukasa Baba, Junzo Hamanishi, Ken D Yamaguchi, Ryusuke Murakami, Mana Taki, Masayo Ukita, Yuko Hosoe et al. · 2020 · British Journal of Cancer
Lactic Acidosis Together with GM-CSF and M-CSF Induces Human Macrophages toward an Inflammatory Protumor Phenotype
Léa Paolini, Clément Adam, Céline Beauvillain, Laurence Preisser, Simon Blanchard, Pascale Pignon, Valérie Seegers, Louise-Marie Chevalier, Mario Campone, Romuald Wernert et al. · 2020 · Cancer Immunology Research
Alternative RNA splicing and cancer
Sali Liu, Chonghui Cheng · 2013 · Wiley Interdisciplinary Reviews - RNA
Current Limitations and Novel Perspectives in Pancreatic Cancer Treatment
Steve Robatel, Mirjam Schenk · 2022 · Cancers
Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response
Michel J.P. DuPage, Tyler Jacks · 2013 · Current Opinion in Immunology
The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer
Nicola E. Annels, Victoria E. Shaw, Rachel F. Gabitass, Lucinda Jane Billingham, Pippa G. Corrie, Martin McKinlay Eatock, Juan W. Valle, David B. Smith, Jonathan Wadsley, David Cunningham et al. · 2013 · Cancer Immunology Immunotherapy
Retinoblastoma Inactivation Induces a Protumoral Microenvironment via Enhanced CCL2 Secretion
Fengkai Li, Shunsuke Kitajima, Susumu Kohno, Akiyo Yoshida, Shoichiro Tange, Soichiro Sasaki, Nobuhiro Okada, Yuuki Nishimoto, Hayato Muranaka, Naoko Nagatani et al. · 2019 · Cancer Research
Myeloid‐Derived Suppressor Cells and Therapeutic Strategies in Cancer
Hiroshi Katoh, Masahiko Watanabe · 2015 · Mediators of Inflammation
The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance
Renee B. Chang, Gregory Lawrence Beatty · 2020 · Journal of Leukocyte Biology
Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice
Benson Chellakkan Selvanesan, Dinesh Chandra, Wilber Quispe‐Tintaya, Arthee Jahangir, Ankur S. Patel, Kiran Meena, Rodrigo Alberto Alves da Silva, Madeline Friedman, Lisa R. Gabor, Olivia R Khouri et al. · 2022 · Science Translational Medicine
Pancreatic cancer: The microenvironment needs attention too!
Minoti Vivek Apte, Zhihong Xu, Srinivasa P. Pothula, David Goldstein, Romano C. Pirola, Jeremy S. Wilson · 2015 · Pancreatology
Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells
Engin Gürlevik, Bettina Fleischmann-Mundt, Jennifer Brooks, İhsan Ekin Demir, Katja Steiger, Silvia Ribback, Tetyana Yevsa, Norman Woller, Arnold Kloos, Dmitrij Ostroumov et al. · 2016 · Gastroenterology
Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation
Tim D.D. Somerville, Giulia Biffi, Juliane Daßler‐Plenker, Stella K. Hur, Xue‐Yan He, Krysten E. Vance, Koji Miyabayashi, Yali Xu, Diogo Maia-Silva, Olaf Klingbeil et al. · 2020 · eLife
Kras and tumor immunity: friend or foe?
Cullis, Jane, Das, Shipra, Bar-Sagi, Dafna · 2018 · Cold Spring Harbor Perspectives in Medicine
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
Meredith L. Stone, Gregory Lawrence Beatty · 2019 · Pharmacology & Therapeutics
The Pleiotropic Effects of the GM-CSF Rheostat on Myeloid Cell Differentiation and Function: More Than a Numbers Game
Yifan Zhan, Andrew M. Lew, Michaël Chopin · 2019 · Frontiers in Immunology
Generation of Myeloid Cells in Cancer: The Spleen Matters
Chong Wu, Qiaomin Hua, Limin Zheng · 2020 · Frontiers in Immunology
Roles of Neutrophils in Glioma and Brain Metastases
Ya-Jui Lin, Kuo‐Chen Wei, Pin‐Yuan Chen, Michael K. Lim, Tsong‐Long Hwang · 2021 · Frontiers in Immunology
Fas and TRAIL ‘death receptors’ as initiators of inflammation: Implications for cancer
Sean P. Cullen, Séamus J. Martin · 2015 · Seminars in Cell and Developmental Biology
The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration
Jennifer Watt, Hemant Mahendrakumar Kocher · 2013 · OncoImmunology
Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors
Mohammed I. El–Gamal, Shahad K. Al-Ameen, Dania M. Al-Koumi, Mawadda G. Hamad, Nouran A. Jalal, Chang‐Hyun Oh · 2018 · Journal of Medicinal Chemistry
Biology and therapeutic targeting of tumour‐associated macrophages
Tim Beltraminelli, Michele De Palma · 2020 · The Journal of Pathology
Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer
Sayeda Yasmin‐Karim, Patrick T. Bruck, Michèle Moreau, Sijumon Kunjachan, Gui Zhen Chen, Rajiv Kumar, Stephanie Grabow, Stephanie K. Dougan, Wilfred F. Ngwa · 2018 · Frontiers in Immunology
Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma
Albrecht Neeße, Thomas Mathias Gress, David A. Tuveson, Patrick Michl, Sebastian Krug · 2013 · OncoTargets and Therapy
Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment
Cara C. Schafer, Yong Wang, Kenneth P. Hough, Anandi Sawant, Stefan C. Grant, Victor John Thannickal, Jaroslaw W. Zmijewski, Selvarangan Ponnazhagan, Jessy S. Deshane · 2016 · Oncotarget
Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
Michael Lawrence Dougan, Jessica R. Ingram, Hee‐Jin Jeong, Munir M. Mosaheb, Patrick T. Bruck, Lestat R. Ali, Novalia Pishesha, Olga S. Blomberg, Paul M. Tyler, Mariah M. Servos et al. · 2018 · Cancer Immunology Research
Using chemo-drugs or irradiation to break immune tolerance and facilitate immunotherapy in solid cancer
Yawen Zheng, Yan Dou, Lili Duan, Changsheng Cong, Aiqin Gao, Qinghua Lai, Yuping Sun · 2015 · Cellular Immunology
Chemokine (C‐X‐C motif) ligand 1 and CXCL 2 produced by tumor promote the generation of monocytic myeloid‐derived suppressor cells
Huifang Shi, Xiaoqing Han, Yingying Sun, Chao Shang, Min Wei, Xueqing Ba, Xianlu Zeng · 2018 · Cancer Science
Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy
Despina Siolas, Emily Vucic, Emma Kurz, Cristina H Hajdu, Dafna Bar‐Sagi · 2020 · Cell Reports
Stress Granules Determine the Development of Obesity-Associated Pancreatic Cancer
Guillaume Fonteneau, Alexandra Redding, Hannah Hoag-Lee, Edward S. Sim, Stefan Heinrich, Matthias M. Gaida, Elda Grabocka · 2022 · Cancer Discovery
Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site
Elaheh Nasrollahzadeh, Sepideh Razi, Mahsa Keshavarz‐Fathi, Massimiliano Mazzone, Nima Rezaei · 2020 · Cancer Immunology Immunotherapy